Sunday, December 17, 2017
In 1914 the Europeans (including the British) ruled the world. Their empires spanned the globe, their culture reigned supreme, financially they were the center of the world, their science was a marvel and they had convinced themselves and a...
Yesterday an article came out on Bloomberg that discussed the issues with reimbursement on Gilead's latest drug, Yescarta. For those who don't know, Yescarta is a CAR-T therapy that was developed by KITE Pharmaceuticals. CAR-T is the hottest space...
DALLAS and MUMBAI, India, Dec. 14, 2017 /PRNewswire/ -- MoneyOnMobile, Inc. (MOMT) today reported November 2017 financial results, including the following highlights: November 2017 net revenue was $916k, more than three times November 2016 net revenue November 2017 was down from October 2017 by 8% November 2017 was up from September 2017 by 22% Total monthly net...
I get this question often, why would both these companies, who are competitors in many ways, share their data with KanKan? Investors scratch their head wondering what the motivation is behind this. In a phone call last week, I had...
Tailwinds' Take: SGBX shares have been under tax-loss pressure as we end 2017, but business is booming. "Momentum with our sales is clearly accelerating as we close the fourth quarter of 2017". Expect this divergence to end soon, as...
Tailwinds' Take: the implications of this study are potentially massive. It truly appears that NR has many positive effects and is well on its way to becoming a blockbuster supplement. No side effects, many benefits. There appears to be...
Tailwinds' Take: an incremental positive that moves the needle towards 2018 guidance, the big news is a ShenHua partnership, since it's an SOE, is a partnership with the Government of China.  LAS VEGAS, Dec. 13, 2017 /PRNewswire/ -- Remark Holdings, Inc. (NASDAQ: MARK),...
I had the pleasure of meeting Shing Tao, the CEO of Remark Holdings (NASDAQ:MARK), on Monday night. He had just flown into San Francisco from Beijing and I was meant to be his first meeting before dinner and some...
Tailwinds' Take: I love it when companies decide not to dilute their investors. ITUS' model is one of partnerships and joint-ventures. This is very positive long-term for shareholders. Plus, love this quote, "many exciting opportunities ahead of us." 2018...
Like Kevin Costner in Field of Dreams, Paul Travers was a little ahead of himself when he started Vuzix. There must have been a voice in his head saying, "if you build it, they will buy," because he kept...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address